FI108134B - Loracarbef-hydrokloridi-C1-C3-alkoholisolvaatit ja menetelmä loracarbefin eristämiseksi - Google Patents
Loracarbef-hydrokloridi-C1-C3-alkoholisolvaatit ja menetelmä loracarbefin eristämiseksi Download PDFInfo
- Publication number
- FI108134B FI108134B FI942798A FI942798A FI108134B FI 108134 B FI108134 B FI 108134B FI 942798 A FI942798 A FI 942798A FI 942798 A FI942798 A FI 942798A FI 108134 B FI108134 B FI 108134B
- Authority
- FI
- Finland
- Prior art keywords
- loracarbef
- hydrochloride
- alcohol
- formula
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/077,305 US5550231A (en) | 1993-06-15 | 1993-06-15 | Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof |
| US7730593 | 1993-06-15 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI942798A0 FI942798A0 (fi) | 1994-06-13 |
| FI942798A FI942798A (fi) | 1994-12-16 |
| FI108134B true FI108134B (fi) | 2001-11-30 |
Family
ID=22137301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI942798A FI108134B (fi) | 1993-06-15 | 1994-06-13 | Loracarbef-hydrokloridi-C1-C3-alkoholisolvaatit ja menetelmä loracarbefin eristämiseksi |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US5550231A (ja) |
| EP (1) | EP0629625B1 (ja) |
| JP (1) | JP3474635B2 (ja) |
| KR (1) | KR100310947B1 (ja) |
| AT (1) | ATE225789T1 (ja) |
| BR (1) | BR9402406A (ja) |
| CA (1) | CA2125762A1 (ja) |
| DE (1) | DE69431498T2 (ja) |
| ES (1) | ES2184751T3 (ja) |
| FI (1) | FI108134B (ja) |
| HU (1) | HUT67489A (ja) |
| IL (1) | IL109989A (ja) |
| TW (1) | TW380139B (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA978515B (en) * | 1996-09-23 | 1999-03-23 | Lilly Co Eli | Intermediates and process for preparing olanzapine |
| US20060205938A1 (en) * | 2002-11-21 | 2006-09-14 | Yatendra Kumar | Monohydrate solvates of loracarbef |
| EP1603399B1 (fr) * | 2003-03-12 | 2009-12-23 | LESAFFRE et Cie | Levain panaire, son utilisation et produits de boulangerie cuits susceptibles d'être obtenus |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4168376A (en) * | 1978-06-05 | 1979-09-18 | Eli Lilly And Company | Process for crystalline sodium cefamandole |
| US4316958A (en) * | 1979-02-10 | 1982-02-23 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing optically active cephalosporin analogs |
| JPS5672698A (en) * | 1979-11-14 | 1981-06-16 | Kyowa Hakko Kogyo Co Ltd | Preparation of optically active cephalosporin analogue |
| US4332896A (en) * | 1979-04-14 | 1982-06-01 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing cephalosporin analogs |
| US4775751A (en) * | 1985-06-03 | 1988-10-04 | Eli Lilly & Company | Process for cephalexin hydrochloride alcoholates |
| DD273634A5 (de) * | 1987-10-06 | 1989-11-22 | ����@�����@�����@����k�� | Verfahren zur herstellung eines kristallinen monohydrats eines 1-carbacephalosporins |
| CA2002596A1 (en) * | 1988-11-14 | 1990-05-14 | Thomas M. Eckrich | Hydrates of b-lactam antibiotic |
| CA2002597C (en) * | 1988-11-14 | 1999-03-23 | Thomas M. Eckrich | Solvates of b-lactam antibiotic |
| US4977257A (en) * | 1988-11-14 | 1990-12-11 | Eli Lilly And Company | DMF solvates of a β-lactam antibiotic |
| CA2034592C (en) * | 1990-01-26 | 2001-06-05 | Ralph R. Pfeiffer | Crystalline hydrochloride of new beta-lactam antibiotic and process therefor |
| US5057607A (en) * | 1990-06-08 | 1991-10-15 | Eli Lilly And Company | Enantiomerically selective biocatalyzed acylation |
| US5352782A (en) * | 1993-06-04 | 1994-10-04 | Eli Lilly And Company | Process for preparing crystalline β-lactam monohydrate |
| US5374719A (en) * | 1993-06-04 | 1994-12-20 | Eli Lilly And Company | Process for converting loracarbef dihydrate to loracarbef monohydrate |
| US5399686A (en) * | 1993-06-04 | 1995-03-21 | Eli Lilly And Company | Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate |
| US5412094A (en) * | 1993-06-28 | 1995-05-02 | Eli Lilly And Company | Bicyclic beta-lactam/paraben complexes |
-
1993
- 1993-06-15 US US08/077,305 patent/US5550231A/en not_active Expired - Lifetime
-
1994
- 1994-06-11 TW TW083105321A patent/TW380139B/zh not_active IP Right Cessation
- 1994-06-13 FI FI942798A patent/FI108134B/fi not_active IP Right Cessation
- 1994-06-13 JP JP13023494A patent/JP3474635B2/ja not_active Expired - Fee Related
- 1994-06-13 EP EP94304230A patent/EP0629625B1/en not_active Expired - Lifetime
- 1994-06-13 HU HU9401765A patent/HUT67489A/hu unknown
- 1994-06-13 KR KR1019940013210A patent/KR100310947B1/ko not_active IP Right Cessation
- 1994-06-13 DE DE69431498T patent/DE69431498T2/de not_active Expired - Fee Related
- 1994-06-13 IL IL109989A patent/IL109989A/en not_active IP Right Cessation
- 1994-06-13 ES ES94304230T patent/ES2184751T3/es not_active Expired - Lifetime
- 1994-06-13 CA CA002125762A patent/CA2125762A1/en not_active Abandoned
- 1994-06-13 AT AT94304230T patent/ATE225789T1/de not_active IP Right Cessation
- 1994-06-14 BR BR9402406A patent/BR9402406A/pt not_active Application Discontinuation
-
1995
- 1995-05-18 US US08/444,124 patent/US5578720A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| KR950000704A (ko) | 1995-01-03 |
| US5578720A (en) | 1996-11-26 |
| HUT67489A (en) | 1995-04-28 |
| FI942798A0 (fi) | 1994-06-13 |
| TW380139B (en) | 2000-01-21 |
| IL109989A0 (en) | 1994-10-07 |
| JPH0770122A (ja) | 1995-03-14 |
| JP3474635B2 (ja) | 2003-12-08 |
| US5550231A (en) | 1996-08-27 |
| HU9401765D0 (en) | 1994-09-28 |
| DE69431498D1 (de) | 2002-11-14 |
| KR100310947B1 (ko) | 2001-12-28 |
| EP0629625A1 (en) | 1994-12-21 |
| ATE225789T1 (de) | 2002-10-15 |
| BR9402406A (pt) | 1995-01-17 |
| FI942798A (fi) | 1994-12-16 |
| IL109989A (en) | 1998-06-15 |
| CA2125762A1 (en) | 1994-12-16 |
| ES2184751T3 (es) | 2003-04-16 |
| EP0629625B1 (en) | 2002-10-09 |
| DE69431498T2 (de) | 2003-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI81780B (fi) | Disubstituerade prolinderivat, foerfarande foer deras framstaellning och deras anvaendning. | |
| RU2108334C1 (ru) | Способ получения гексагидро-8-метилпирроло[2,3-b]-индольных соединений | |
| US5101040A (en) | Process for the industrial preparation of 4-chloro-3-sulfamoyl-n-(2,3-dihydro-2-methyl-1h-indol-1-yl)benzamide | |
| US4895943A (en) | Preparation of 1,4-diazabicyclo(3.2.2)nonane | |
| JP3639449B2 (ja) | ３−アミノ−ピロリジン誘導体の製造方法 | |
| FI108134B (fi) | Loracarbef-hydrokloridi-C1-C3-alkoholisolvaatit ja menetelmä loracarbefin eristämiseksi | |
| US6197998B1 (en) | Process for producing N-glycyltyrosine and its crystal structure | |
| KR20060109965A (ko) | 키랄 염기 환형 아미드와의 염 형성에 의해, 임의로 치환된만델산을 분해하는 방법 | |
| JP4852528B2 (ja) | オキシカルバゼピンの製造方法 | |
| RU2069659C1 (ru) | Способ восстановления карбонилсодержащего производного акридина или его фармацевтически приемлемой кислотно-аддитивной соли | |
| JP2007528385A6 (ja) | オキシカルバゼピンの製造方法 | |
| GB1601701A (en) | Production of heterocyclic benzamide compounds | |
| EP2032581B1 (en) | Enantiomerically enriched compounds and process | |
| AU637719B2 (en) | Process for preparing 1-((2s)-3-mercapto-methyl-1-oxopropyl)-l-proline | |
| JP2681873B2 (ja) | チザニジンの製造方法 | |
| US4816580A (en) | Improved method for preparing penicillanic acid derivatives | |
| Shiraiwa et al. | Optical resolution by preferential crystallization of (RS)‐2‐amino‐3‐chloropropanoic acid hydrochloride | |
| US6426417B1 (en) | Processes and intermediates useful to make antifolates | |
| JPH0665198A (ja) | ４−クロロ−３−スルファモイル−ｎ−（２，３−ジヒドロ−２−メチル−１ｈ−インドール−１−イル）ベンズアミドを工業的に製造するための新規な方法 | |
| KR100368895B1 (ko) | 1,2,3,9-테트라하이드로-9-메틸-3-[(2-메틸-1ｈ-이미다졸-1-일)메틸]-4ｈ-카바졸-4-온의 제조방법 | |
| US6313315B1 (en) | Methods for producing N-protected-azetidine-2-carboxylic acids | |
| JPS59134796A (ja) | ６−アミノペニシラン酸のテトラアルキルアンモニウム塩を用いる６−アミノペニシラン酸エステルの製造法 | |
| KR100393744B1 (ko) | 1,2,3,9-테트라하이드로-9-메틸-3-[(2-메틸-1ｈ-이미다졸-1-일)메틸]-4ｈ-카바졸-4-온의 제조방법 | |
| KR900008171B1 (ko) | 벤조디아제핀 아세테이트화합물의 제조방법 | |
| EA004675B1 (ru) | СПОСОБ ПОЛУЧЕНИЯ ЗАМЕЩЕННЫХ [1,4]ДИАЗЕПИНО[6,7,1-hi]ИНДОЛ-4-ОНОВ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Patent expired |